Heska Corp. (NASDAQ:HSKA)’s share price fell 3.8% on Wednesday . The stock traded as low as $52.99 and last traded at $53.57, with a volume of 115,948 shares. The stock had previously closed at $55.68.

Several research firms have weighed in on HSKA. B. Riley downgraded Heska Corp. from a “buy” rating to a “neutral” rating and raised their price target for the stock from $52.50 to $53.00 in a research report on Wednesday. Zacks Investment Research raised Heska Corp. from a “hold” rating to a “strong-buy” rating and set a $57.00 price target for the company in a research report on Friday, August 5th. TheStreet raised Heska Corp. from a “hold” rating to a “buy” rating in a research report on Wednesday, May 25th. Gabelli downgraded Heska Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Finally, Sidoti began coverage on Heska Corp. in a research report on Friday, July 1st. They set a “buy” rating and a $49.00 price target for the company. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $53.00.

The firm has a market capitalization of $374.69 million, a price-to-earnings ratio of 55.22 and a beta of 0.48. The company’s 50 day moving average price is $52.24 and its 200 day moving average price is $39.21.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/heska-corp-hska-trading-down-3-8.html

Heska Corp. (NASDAQ:HSKA) last released its earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.17. The firm earned $30 million during the quarter, compared to the consensus estimate of $28.47 million. Heska Corp. had a return on equity of 8.75% and a net margin of 6.22%. The firm’s revenue for the quarter was up 25.5% compared to the same quarter last year. On average, analysts expect that Heska Corp. will post $1.12 EPS for the current year.

In other Heska Corp. news, EVP Steve Asakowicz sold 4,698 shares of the company’s stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $52.55, for a total value of $246,879.90. Following the completion of the sale, the executive vice president now directly owns 12,858 shares in the company, valued at $675,687.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jason A. Napolitano sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, September 1st. The stock was sold at an average price of $52.53, for a total value of $262,650.00. The disclosure for this sale can be found here. 15.30% of the stock is owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the company. Monarch Partners Asset Management LLC purchased a new stake in Heska Corp. during the second quarter worth $255,000. Strs Ohio increased its stake in Heska Corp. by 8.6% in the second quarter. Strs Ohio now owns 16,500 shares of the company’s stock worth $613,000 after buying an additional 1,300 shares during the period. Bank of Montreal Can purchased a new stake in Heska Corp. during the second quarter worth $128,000. Pembroke Management LTD purchased a new stake in Heska Corp. during the second quarter worth $5,096,000. Finally, Adams Diversified Equity Fund Inc. purchased a new stake in Heska Corp. during the second quarter worth $279,000. Hedge funds and other institutional investors own 68.32% of the company’s stock.

Heska Corp. Company Profile

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

5 Day Chart for NASDAQ:HSKA

Receive News & Ratings for Heska Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp. and related companies with MarketBeat.com's FREE daily email newsletter.